Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2023/03/050496
CTRI/2023/03/050496
Not yet recruiting
Phase 2

An open label randomized controlled trial to evaluate the efficacy of Bhunimbadi Vati and its add on effect with Tablet Glimepiride Metformin in the management of Madhumeha with special reference to Type 2 Diabetes mellitus

Dr Kiran Damoo Ubhe0 sites0 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsHealth Condition 1: E119- Type 2 diabetes mellitus without complications

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Health Condition 1: E119- Type 2 diabetes mellitus without complications
Sponsor
Dr Kiran Damoo Ubhe
Status
Not yet recruiting
Last Updated
3 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional

Investigators

Sponsor
Dr Kiran Damoo Ubhe

Eligibility Criteria

Inclusion Criteria

  • •1\. Age group\- between 40\-70 years
  • •2\. Gender\- Male \& female both
  • •3\. Known case of Madhumeha according to symptoms\- patient passes frequently, large
  • •quantity and turbid urine (Prabhutaavilamutrata).
  • •Type II diabetic having symptomsPolyphagia, Polyuria, Polydipsia, on treatment and newly diagnosed Type II diabetic who
  • •are suffering for not more than 10 years.
  • •4\. Patients with fasting blood sugar more than 126\-250 mg/dl and post prandial blood sugar
  • •more than 200\-350 mg/dl.
  • •(Patients with fasting blood sugar more than 126 mg/dl and post prandial blood sugar
  • •more than 200 mg/dl)

Exclusion Criteria

  • •1\. K/C/O Madhumeha who are already taking Ayurvedic medicine for same.
  • •2\. K/C/O Type 1 Diabetes, K/C/O Acromegaly, K/C/O Cushingâ??s syndrome, K/C/O pancreatic disorder
  • •3\. Patient under insulin therapy
  • •4\. Pregnant and lactating mothers
  • •5\. Patients with acute complications like hyperglycemic coma, ketoacidosis and infections like gangrene
  • •6\. K/C/O Nephropathy, K/C/O Neuropathy, K/C/O retinopathy
  • •7\. Patients with immune compromised disease

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Phase 2
Effect of cholestyramine on post-ESD ulcer healing
JPRN-jRCTs031200235Tamura Shigeki100
Not yet recruiting
Not Applicable
A trial to assess the role of serial physical examination for well appearing babies at risk of sepsis
CTRI/2024/04/066566ONE
Completed
Not Applicable
An open-label randomized controlled trial to assess the efficacy and safety of chronic hepatitis C and compensated cirrhosis patients with the prescribing pattern of vitaminD plus peginterferon alpha-2a /ribavirin.Chronic hepatitisC patients and compensated cirrhosis patients
JPRN-UMIN000008342Saitama Medical University80
Completed
Not Applicable
An open-label randomized controlled trial to assess the efficacy and safety of chronic hepatitis C patients with vitaminD plus peginterferon alpha-2a /ribavirin.versus alfacalcidol plus peginterferon alpha-2a /ribavirin.Chronic hepatitis C patients with genotype 1 and high viral load (&gt= 5 Log IU/mL)
JPRN-UMIN000004210Saitama Medical University40
Not yet recruiting
Phase 3
Effect of Dapagliflozin on Unconscious functions of the heart in Diabetic Patients.Health Condition 1: E119- Type 2 diabetes mellitus without complications
CTRI/2024/04/065339Krishna Keerthi Annepu